Results 31 to 40 of about 88,424,874 (248)
Progressive accumulation of amyloid-β (Aβ) plaques in the brain is a characteristic pathological change in Alzheimer’s disease (AD). We previously found the expression of lipoprotein lipase (LPL) was increased in SH-SY5Y cells exposed to low-dose Aβ and ...
Jingzhu Zhang +6 more
doaj +1 more source
Metastasis is a leading cause of mortality in patients with lung adenocarcinoma. Histone deacetylases have emerged as promising targets for anti-tumor drugs, with histone deacetylase inhibitors (HDACi) being an active area of research.
Dongmei Wang +8 more
doaj +1 more source
Histone deacetylase 3 is required for iNKT cell development
NKT cells are a distinct subset that have developmental requirements that often differ from conventional T cells. Here, we show that NKT-specific deletion of Hdac3 results in a severe reduction in the number of iNKT cells, particularly of NKT1 cells.
Puspa Thapa +4 more
doaj +1 more source
HDAC2 (histone deacetylase 2) [PDF]
Review on HDAC2 (histone deacetylase 2), with data on DNA, on the protein encoded, and where the gene is ...
Esteller, M +3 more
core +1 more source
Mycobacterium tuberculosis (Mtb) inhibits autophagy to promote its survival in host cells. However, the molecular mechanisms by which Mtb inhibits autophagy are poorly understood.
Srabasti Sengupta +6 more
doaj +1 more source
Recent improvements in molecular sub typing of Non Hodgkin’s lymphomashave resulted in targeted therapies becoming incorporated into treatmentparadigms.
Nolan, David Francis Luke
core +2 more sources
Histone deacetylase 3 promotes RCAN1 stability and nuclear translocation.
Regulator of calcineurin 1 (RCAN1; also referred as DSCR1 or MCIP1) is located in close proximity to a Down syndrome critical region of human chromosome 21.
Kyung Ah Han +8 more
doaj +1 more source
Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation
Background The clinical use of chromatin-modulating drugs, such as histone deacetylase inhibitors, for the treatment of bone marrow failure and hematopoietic malignancies has increased dramatically over the last few years.
Marije Bartels +4 more
doaj +1 more source
HDAC1/2/3 are major histone desuccinylases critical for promoter desuccinylation
Lysine succinylation is one of the major post-translational modifications occurring on histones and is believed to have significant roles in regulating chromatin structure and function.
Jialun Li +11 more
doaj +1 more source
High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors
Epigenetic modification of chromatin is involved in non-malignant pituitary neoplasia by causing abnormal expression of tumor suppressors and oncogenes.
Wenxiu Zhao +11 more
doaj +1 more source

